Objective Guidelines mandate expert pathology review of Barrett's oesophagus (BO) biopsies that reveal dysplasia, but there are no evidence-based standards to corroborate expert reviewer status. We investigated BO concordance rates and pathologist features predictive of diagnostic discordance. Design Pathologists (n=51) from over 20 countries assessed 55 digitised BO biopsies from across the diagnostic spectrum, before and after viewing matched p53 labelling. Extensive demographic and clinical experience data were obtained via online questionnaire. Reference diagnoses were obtained from a review panel (n=4) of experienced Barrett's pathologists. Results We recorded over 6000 case diagnoses with matched demographic data. Of 2805H &E diagno...
AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's oesophagus...
OBJECTIVES: Published data on the natural history of low-grade dysplasia (LGD) in Barrett's esophagu...
Objective Guidelines mandate expert pathology review of Barrett’s oesophagus (BO) biopsies that reve...
Background: Dysplasia assessment of Barrett's esophagus biopsies is associated with low observer agr...
There is suboptimal inter-observer agreement, even among expert gastrointestinal pathologists, in th...
Background: Dysplasia assessment of Barrett’s esophagus biopsies is associated with low observer agr...
AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
Aims: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
AIMS: To determine interobserver variation in grading of dysplasia in Barrett's oesophagus (BO) betw...
This thesis describes the set-up of the national digital review panel for histopathologic evaluation...
Background: Dysplasia in Barrett's esophagus (BE) biopsies is associated with low observer agreement...
AIMS: Interobserver agreement for dysplasia in Barrett's oesophagus (BO) is low, and guidelines advi...
Interobserver agreement for dysplasia in Barrett's oesophagus (BO) is low and guidelines advise expe...
AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's oesophagus...
OBJECTIVES: Published data on the natural history of low-grade dysplasia (LGD) in Barrett's esophagu...
Objective Guidelines mandate expert pathology review of Barrett’s oesophagus (BO) biopsies that reve...
Background: Dysplasia assessment of Barrett's esophagus biopsies is associated with low observer agr...
There is suboptimal inter-observer agreement, even among expert gastrointestinal pathologists, in th...
Background: Dysplasia assessment of Barrett’s esophagus biopsies is associated with low observer agr...
AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
Aims: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
AIMS: To determine interobserver variation in grading of dysplasia in Barrett's oesophagus (BO) betw...
This thesis describes the set-up of the national digital review panel for histopathologic evaluation...
Background: Dysplasia in Barrett's esophagus (BE) biopsies is associated with low observer agreement...
AIMS: Interobserver agreement for dysplasia in Barrett's oesophagus (BO) is low, and guidelines advi...
Interobserver agreement for dysplasia in Barrett's oesophagus (BO) is low and guidelines advise expe...
AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is a...
Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's oesophagus...
OBJECTIVES: Published data on the natural history of low-grade dysplasia (LGD) in Barrett's esophagu...